NCT00693654View on ClinicalTrials.gov

Comparative Study of the Efficacy of SARNA Sensitive Lotion for Treatment of Uremic Itch in Adult Hemodialysis Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

November 30, 2006

Study Completion Date

October 31, 2008

Conditions
Pruritis
Interventions
DRUG

Sarna

Active Ingredient: Pramoxine Hydrochloride Inactive ingredients:Benzyl Alcohol, Carbomer 940, Cetyl Alcohol, Dimethicone, Glyceryl Stearate (\&) PEG-100 Stearate, Isopropyl Myristate, Petrolatum, PEG 8 Stearate, Purified Water, Stearic Acid, Sodium Hydroxide

DRUG

Cetaphil

Purified Water, Glycerin, Hydrogenated Polyisobutene, Cetearyl Alcohol, Ceteareth 20, Macadamia Nut Oil, Dimethicone, Tocopheryl Acetate, Stearoxytrimethylsilane, Stearyl Alcohol, Panthenol, Farnesol, Benzyl Alcohol, Phenoxyethanol, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Sodium Hydroxide, Citric Acid

Trial Locations (1)

27157

Wake Forest University Health Sciences Dermatology, Winston-Salem

All Listed Sponsors
collaborator

Stiefel, a GSK Company

INDUSTRY

lead

Wake Forest University

OTHER

NCT00693654 - Comparative Study of the Efficacy of SARNA Sensitive Lotion for Treatment of Uremic Itch in Adult Hemodialysis Patients | Biotech Hunter | Biotech Hunter